{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:31:45Z","timestamp":1794641505854,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,7,11]],"date-time":"2005-07-11T00:00:00Z","timestamp":1121040000000},"content-version":"vor","delay-in-days":1167,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Eukaryotic Microbiology"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p>\n                    <jats:bold>ABSTRACT.<\/jats:bold>\n                    Nitazoxanide, a 5\u2010nitrothiazolyl derivative, is effective in the treatment of a broad range of parasitic infections. In vitro, it is active against several protozoa, including\n                    <jats:italic>Cryptosporidiwn parvum, Blastocystis hominis<\/jats:italic>\n                    , and\n                    <jats:italic>Giardia intestinalis<\/jats:italic>\n                    . The objective of this study was to determine the in vitro effect of nitazoxanide on the growth and morphology of three anaerobic protozoa\n                    <jats:italic>(Entamoeba histolytica, Giardia intestinalis<\/jats:italic>\n                    , and\n                    <jats:italic>Trichomonas vaginalis<\/jats:italic>\n                    ) and to compare these effects with those of metronidazole and albendazole. A subculture method was used to determine the concentrations required to inhibit growth by 50% or 90% (IC\n                    <jats:sub>50<\/jats:sub>\n                    and IC\n                    <jats:sub>90<\/jats:sub>\n                    ). Nitazoxanide exhibited IC\n                    <jats:sub>50<\/jats:sub>\n                    and IC\n                    <jats:sub>90<\/jats:sub>\n                    values of 0.017 and 0.776 \u03bcg\/ml respectively, against\n                    <jats:italic>E. histolytica<\/jats:italic>\n                    , 0.004 and 0.067 \u03bcg\/ml against G.\n                    <jats:italic>intestinalis<\/jats:italic>\n                    , and 0.034 and 2.04 6 \u03bcg\/ml against\n                    <jats:italic>T. vaginalis<\/jats:italic>\n                    . Based on the IC\n                    <jats:sub>90<\/jats:sub>\n                    values, nitazoxanide was more toxic than metronidazole and albendazole against\n                    <jats:italic>E. histolytica<\/jats:italic>\n                    ; albendazole and nitazoxanide were more toxic than metronidazole against G.\n                    <jats:italic>intestinalis<\/jats:italic>\n                    ; and metronidazole was the most toxic drug against\n                    <jats:italic>T. vaginalis<\/jats:italic>\n                    . The effects of nitazoxanide on trophozoite ultrastructure of all three parasites included cell swelling and distorted cell shape, a redistribution of vacuoles, plasma membrane damage, and the formation of extensive empty areas in the cytoplasm of the protozoa.\n                  <\/jats:p>","DOI":"10.1111\/j.1550-7408.2002.tb00523.x","type":"journal-article","created":{"date-parts":[[2005,7,11]],"date-time":"2005-07-11T14:07:52Z","timestamp":1121090872000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["In Vitro Effect of Nitazoxanide Against\n                    <i>Entamoeba histolytica, Giardia intestinalis<\/i>\n                    and\n                    <i>Trichomonas vaginalis<\/i>\n                    Trophozoites"],"prefix":"10.1111","volume":"49","author":[{"given":"ROBERTO","family":"CEDILLO\u2010RIVERA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BIBIANA","family":"CH\u00c1VEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARTURO","family":"GONZ\u00c1LEZ\u2010ROBLES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMPARO","family":"TAPIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILI\u00c1N","family":"Y\u00c9PEZ\u2010MULIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,11]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1086\/320751"},{"key":"e_1_2_5_3_1","first-page":"47","article-title":"Action of metronidazole on Entamoeba histolytica: an ultrastructural study","volume":"22","author":"Agrawal A.","year":"1990","journal-title":"J. Commun. Dis."},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(88)90278-7"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP38387"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-37-3-221"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1992.tb04841.x"},{"key":"e_1_2_5_8_1","first-page":"63","article-title":"Effects of albendazole on Entamoeba histolytica and Giardia intestinalis trophozoites","volume":"23","author":"Chavez B.","year":"1992","journal-title":"Arch. Med. Res."},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/AAC.40.10.2266","article-title":"In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms","volume":"40","author":"Dobreuil L.","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.56.637"},{"key":"e_1_2_5_11_1","volume-title":"Probit analysis","author":"Finney D. L.","year":"1977"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.4.453"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-4758(93)90143-4"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.5.819"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2254-2258.2000"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.1.1"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.5.667"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7519(94)90123-6"},{"key":"e_1_2_5_19_1","first-page":"41","article-title":"Determination in vitro de la susceptibilidad a la nitazoxanida de cuatro aislados de Giardia duodenalis obtenidos de diferentes hu\u00e9spedes","volume":"53","author":"Ponce\u2010Macotela M.","year":"2001","journal-title":"Rev. Invest. Clin."},{"key":"e_1_2_5_20_1","first-page":"122","article-title":"Efectividad y seguridad del mebendazol comparado con la nitazoxanida en el tratamiento de Giardia intestinalis en ni\u00f1os","volume":"64","author":"Rodr\u00edguez\u2010Garc\u00eda R.","year":"1999","journal-title":"Rev. Gastroenterol. Mex."},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(97)90531-9"},{"key":"e_1_2_5_22_1","first-page":"511","article-title":"Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections","volume":"33","author":"Rossignol J. F.","year":"1984","journal-title":"Trans. R. Soc. Trap. Med. Hyg."},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)90974-9"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/321008"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/322038"},{"key":"e_1_2_5_26_1","first-page":"63","article-title":"Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis","volume":"22","author":"Rossignol J. F.","year":"1984","journal-title":"Int. J. Clin. Pharmacol. Thet: Toxicol"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.6.833"},{"key":"e_1_2_5_28_1","first-page":"349","article-title":"Pharmacokinetics of nitazoxanide after single oral dose administration in six healthy volunteers","volume":"34","author":"Stockis A.","year":"1996","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.1996.2.303"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.1.150-164.2001"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008533"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.2.145"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000007200"}],"container-title":["Journal of Eukaryotic Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1550-7408.2002.tb00523.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1550-7408.2002.tb00523.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T20:15:28Z","timestamp":1695845728000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1550-7408.2002.tb00523.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1111\/j.1550-7408.2002.tb00523.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1550-7408.2002.tb00523.x","archive":["Portico"],"relation":{},"ISSN":["1066-5234","1550-7408"],"issn-type":[{"value":"1066-5234","type":"print"},{"value":"1550-7408","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]},"assertion":[{"value":"2005-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}